Article
Identification of Chemotherapeutic Dihydromyricetin With Enhanced Anti-tumor Activity and Biosafety for Muscle Invasive Bladder Cancer
2021-08-09
Abstract excerpt
<title>Abstract</title> <p><bold>Background: </bold>Muscle invasive<bold> </bold>bladder cancer (MIBC) is one of the most common malignant diseases in elderly men, such as veterans. Postoperative chemotherapy plays a vital role in preventing recurrence and metastasis of MIBC. However, fewer of chemotherapeutic drugs with remarkable anti-tumor activity and biosafety are available for clinical treatment.<bold>Metho...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b4e4cddb-6930-5f8d-a355-98d6be9d6f66
- DOI
- 10.21203/rs.3.rs-763057/v1
